GDC-0449 in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
This randomized phase II trial is studying how well GDC-0449 works in treating patients with
recurrent glioblastoma multiforme that can be removed by surgery. GDC-0449 may be effective
in treating patients with glioblastoma multiforme.